$50.39
0.00 (0%)
Wyeth (WYE.DL)
CAPS Rating:
The Company is engaged in the discovery, development, manufacture, distribution and sale of a diversified line of products in three primary businesses: Pharmaceuticals, Consumer Healthcare and Animal Health.

RSS Headlines
Fool UK
Recs
Arbitrage position. Assuming the deal closes as expected over the next 6 months or so, this position should generate an IRR of 17-18% (an 8-9% absolute return), far higher than what I expect the S&P to generate over the same time period.
At over 60 billion I think Wyeth's market capitalization is simply too big for the arbitrage community to absorb, thus creating significant opportunity. Outperform.